Monday - December 17, 2018
Investigators Recruiting for Study of H.P. Acthar Gel in People With Relapsing-Remitting MS
January 11, 2018
NEW YORK, Jan. 11 -- The National Multiple Sclerosis Society issued the following news:

Investigators are recruiting 66 people with relapsing-remitting MS who have had a relapse and did not experience recovery from the relapse after high-dose intravenous or oral steroids. This study aims to determine the safety and effectiveness of H.P. Acthar Gel(R) (repository corticotropin injection, Mallinckrodt Pharmaceuticals), a gel injected under the skin that is designed to provide extended . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

What's your
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products